OctaAlpha1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OctaAlpha1, covering 2018-04-10 to 2018-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency [Phase 2]